- BYD (SEHK:1211) plans to start vehicle production at its new Hungary plant in Q4 2026, its first manufacturing facility in Europe.
- The company has paused plans for a separate factory in Turkey, indicating a change in how it is approaching European expansion.
- Local production in Hungary is intended to help address EU tariffs on Chinese-made electric vehicles.
BYD, listed in Hong Kong under ticker SEHK:1211, is one of the largest electric vehicle and battery producers globally, with a growing presence in overseas markets. European regulators have introduced tariffs on Chinese-made EVs, which has put more attention on where and how manufacturers produce vehicles for the region. Against that backdrop, a confirmed production timeline in Hungary gives investors a clearer view of how BYD is trying to build a local footing in an important EV market.
The decision to pause the Turkish plant suggests management is concentrating resources on the Hungary site first, before potentially adding more capacity in the region. For investors, the key questions from here are how quickly the Hungary facility ramps up once Q4 2026 production begins and how this local footprint influences BYD's positioning against established European and global automakers.
Stay updated on the most important news stories for BYD by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on BYD.
3 things going right for BYD that this headline doesn't cover.
Quick Assessment
- ✅ Price vs Analyst Target: At HK$86.55 versus a consensus target of HK$124.45, the stock trades about 30% below where analysts currently sit.
- ✅ Simply Wall St Valuation: Shares are assessed as trading 69.9% below estimated fair value, which is a wide valuation gap.
- ❌ Recent Momentum: The stock is down 11.8% over the last 30 days, so sentiment has been weak recently.
There's only one way to know the right time to buy, sell or hold BYD. Head to Simply Wall St's company report for the latest analysis of BYD's Fair Value.
Key Considerations
- 📊 The Hungary plant timeline gives more clarity on BYD's on-the-ground presence in Europe, which could be important for how investors view its long term access to the region.
- 📊 Watch progress updates on Hungary capex, EU tariff policies and how European volumes and pricing respond once local production starts in Q4 2026.
- ⚠️ Profit margins are currently 3.5% compared with 5.4% last year, so any cost overruns or delays on the new plant would matter for returns on this investment.
Dig Deeper
For the full picture including more risks and rewards, check out the complete BYD analysis. Alternatively, you can check out the community page for BYD to see how other investors believe this latest news will impact the company's narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if BYD might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap.

Did anyone else notice this narrative (posted over a year ago) was spot on with Moderna’s stock price!!! 🤯
Happy for the melanoma patients. It is no surprise that other companies moved up too. It's the optionality getting priced in.
About SEHK:1211
BYD
Engages in automobiles and batteries business in the People’s Republic of China, Hong Kong, Macau, Taiwan, and internationally.
Excellent balance sheet and good value.